{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:10:16Z","timestamp":1793653816971,"version":"4.5.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cardiovascular Medicine"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.tcm.2023.03.006","type":"journal-article","created":{"date-parts":[[2023,4,2]],"date-time":"2023-04-02T14:36:49Z","timestamp":1680446209000},"page":"279-285","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Opioids-induced inhibition of HERG ion channels and sudden cardiac death, a systematic review of current literature"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9966-0599","authenticated-orcid":false,"given":"Adham","family":"El Sherbini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiera","family":"Liblik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junsu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Baranchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shetuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1807-8397","authenticated-orcid":false,"given":"Mohammad","family":"El-Diasty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tcm.2023.03.006_bib0001","series-title":"Opioid overdose","year":"2021"},{"issue":"5","key":"10.1016\/j.tcm.2023.03.006_bib0002","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1037\/a0013628","article-title":"Opioids and the treatment of chronic pain: controversies, current status, and future directions","volume":"16","author":"Rosenblum","year":"2008","journal-title":"Exp Clin Psychopharmacol"},{"issue":"1","key":"10.1016\/j.tcm.2023.03.006_bib0003","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1186\/1756-0500-5-473","article-title":"Validation of a computer case definition for sudden cardiac death in opioid users","volume":"5","author":"Kawai","year":"2012","journal-title":"BMC Res Notes"},{"issue":"7083","key":"10.1016\/j.tcm.2023.03.006_bib0004","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nature04710","article-title":"hERG potassium channels and cardiac arrhythmia","volume":"440","author":"Sanguinetti","year":"2006","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.tcm.2023.03.006_bib0005","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/0092-8674(95)90358-5","article-title":"A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome","volume":"80","author":"Curran","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.tcm.2023.03.006_bib0006","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.tcm.2023.03.006_bib0007","unstructured":"Covidence systematic review software. 2023 www.covidence.org."},{"issue":"11","key":"10.1016\/j.tcm.2023.03.006_bib0008","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0241362","article-title":"Mechanisms of QT prolongation by buprenorphine cannot be explained by direct hERG channel block","volume":"15","author":"Tran","year":"2020","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.tcm.2023.03.006_bib0009","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1365-2125.2008.03327.x","article-title":"Oxycodone is associated with dose-dependent QTc prolongation in patients and low-affinity inhibiting of hERG activity in vitro","volume":"67","author":"Fanoe","year":"2009","journal-title":"Br J Clin Pharmacol"},{"issue":"22","key":"10.1016\/j.tcm.2023.03.006_bib0010","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1001\/archinte.167.22.2469","article-title":"QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial","volume":"167","author":"Wedam","year":"2007","journal-title":"Arch Intern Med"},{"issue":"14","key":"10.1016\/j.tcm.2023.03.006_bib0011","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0024-3205(98)00383-X","article-title":"Electrophysiological mechanisms for the antiarrhythmic activities of naloxone on cardiac tissues","volume":"63","author":"Hung","year":"1998","journal-title":"Life Sci"},{"issue":"2","key":"10.1016\/j.tcm.2023.03.006_bib0012","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1124\/jpet.102.038240","article-title":"Influence of opioid agonists on cardiac human ether-a-go-go-related gene K(+) currents","volume":"303","author":"Katchman","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"issue":"12","key":"10.1016\/j.tcm.2023.03.006_bib0013","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/j.hrthm.2021.08.028","article-title":"Intracellular uptake of agents that block the hERG channel can confound the assessment of QT interval prolongation and arrhythmic risk","volume":"18","author":"Burashnikov","year":"2021","journal-title":"Heart Rhythm"},{"issue":"1\u20132","key":"10.1016\/j.tcm.2023.03.006_bib0014","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0014-2999(02)02700-0","article-title":"Interactions of the narcotic l-alpha-acetylmethadol with human cardiac K+ channels","volume":"458","author":"Kang","year":"2003","journal-title":"Eur J Pharmacol"},{"issue":"12","key":"10.1016\/j.tcm.2023.03.006_bib0015","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1001\/archinte.166.12.1280","article-title":"Drug-induced long QT syndrome in injection drug users receiving methadone: high frequency in hospitalized patients and risk factors","volume":"166","author":"Ehret","year":"2006","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1016\/j.tcm.2023.03.006_bib0016","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/10550887.2011.610710","article-title":"QT interval screening in methadone maintenance treatment: report of a SAMHSA expert panel","volume":"30","author":"Martin","year":"2011","journal-title":"J Addict Dis"},{"issue":"4","key":"10.1016\/j.tcm.2023.03.006_bib0017","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1124\/mol.118.114751","article-title":"Blockade of the Human Ether A-Go-Go-Related Gene (hERG) potassium channel by fentanyl","volume":"95","author":"Tschirhart","year":"2019","journal-title":"Mol Pharmacol"},{"issue":"3","key":"10.1016\/j.tcm.2023.03.006_bib0018","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0304-3959(03)00205-7","article-title":"QTc interval prolongation associated with intravenous methadone","volume":"105","author":"Kornick","year":"2003","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.tcm.2023.03.006_bib0019","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/FJC.0b013e3181f1d21b","article-title":"Increased cardiac risk in concomitant methadone and diazepam treatment: pharmacodynamic interactions in cardiac ion channels","volume":"56","author":"Kuryshev","year":"2010","journal-title":"J Cardiovasc Pharmacol"},{"issue":"1","key":"10.1016\/j.tcm.2023.03.006_bib0020","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000167043","article-title":"The effects of chiral isolates of methadone on the cardiac potassium channel IKr","volume":"113","author":"Lin","year":"2009","journal-title":"Cardiology"},{"issue":"7","key":"10.1016\/j.tcm.2023.03.006_bib0021","first-page":"473","article-title":"Drug-induced QT prolongation and torsades de pointes","volume":"42","author":"Li","year":"2017","journal-title":"P T Peer Rev J Formul Manag"},{"issue":"4","key":"10.1016\/j.tcm.2023.03.006_bib0022","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/clpt.1987.47","article-title":"Pharmacokinetics and pharmacodynamics of methadone in patients with chronic pain","volume":"41","author":"Inturrisi","year":"1987","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.tcm.2023.03.006_bib0023","doi-asserted-by":"crossref","first-page":"969","DOI":"10.2147\/JPR.S278279","article-title":"Oliceridine: a novel drug for the management of moderate to severe acute pain \u2013 a review of current evidence","volume":"14","author":"Tan","year":"2021","journal-title":"J Pain Res"},{"issue":"1","key":"10.1016\/j.tcm.2023.03.006_bib0024","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1151\/spp021113","article-title":"The neurobiology of opioid dependence: implications for treatment","volume":"1","author":"Kosten","year":"2002","journal-title":"Sci Pract Perspect"},{"issue":"1","key":"10.1016\/j.tcm.2023.03.006_bib0025","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/2047-783X-14-1-7","article-title":"Levo-alpha-acetylmethadol (LAAM) induced QTc-prolongation - results from a controlled clinical trial","volume":"14","author":"Wieneke","year":"2009","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.tcm.2023.03.006_bib0026","unstructured":"EMEA. EMEA public statement on the recommendation to suspend the marketing authorisation for orlaam (Levacetylmethadol) in the European union. Published online April 19, 2001. https:\/\/www.ema.europa.eu\/en\/documents\/public-statement\/public-statement-recommendation-suspend-marketing-authorisation-orlaam-levacetylmethadol-european_en.pdf."},{"issue":"10","key":"10.1016\/j.tcm.2023.03.006_bib0027","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1016\/j.cjca.2018.07.301","article-title":"Molecular mechanisms of fentanyl-mediated sudden death","volume":"34","author":"Tschirhart","year":"2018","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.tcm.2023.03.006_bib0028","article-title":"Fentanyl","year":"2022","journal-title":"Cent Dis Control Prev"},{"issue":"4","key":"10.1016\/j.tcm.2023.03.006_bib0029","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1124\/mol.119.119271","article-title":"Fentanyl-induced block of hERG channels is exacerbated by hypoxia, hypokalemia, alkalosis, and the presence of hERG1b","volume":"98","author":"Tschirhart","year":"2020","journal-title":"Mol Pharmacol"},{"issue":"4","key":"10.1016\/j.tcm.2023.03.006_bib0030","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/J354v16n04_02","article-title":"Clinical pharmacokinetics of morphine","volume":"16","author":"Lugo","year":"2002","journal-title":"J Pain Palliat Care Pharmacother"},{"issue":"3","key":"10.1016\/j.tcm.2023.03.006_bib0031","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/bja\/86.3.413","article-title":"Codeine phosphate in paediatric medicine","volume":"86","author":"Williams","year":"2001","journal-title":"Br J Anaesth"},{"issue":"4","key":"10.1016\/j.tcm.2023.03.006_bib0032","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1177\/0310057X0002800403","article-title":"Tramadol-present and future","volume":"28","author":"Shipton","year":"2000","journal-title":"Anaesth Intensive Care"},{"issue":"5","key":"10.1016\/j.tcm.2023.03.006_bib0033","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jpainsymman.2005.01.010","article-title":"Oxycodone","volume":"29","author":"Kalso","year":"2005","journal-title":"J Pain Symptom Manag."},{"issue":"9","key":"10.1016\/j.tcm.2023.03.006_bib0034","doi-asserted-by":"crossref","first-page":"4758","DOI":"10.1021\/acs.jcim.1c00744","article-title":"Structure-based prediction of hERG-related cardiotoxicity: a benchmark study","volume":"61","author":"Creanza","year":"2021","journal-title":"J Chem Inf Model"},{"issue":"Pt 17","key":"10.1016\/j.tcm.2023.03.006_bib0035","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1113\/jphysiol.2010.194670","article-title":"Revealing the structural basis of action of hERG potassium channel activators and blockers","volume":"588","author":"Perry","year":"2010","journal-title":"J Physiol"},{"key":"10.1016\/j.tcm.2023.03.006_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112290","article-title":"hERG toxicity assessment: useful guidelines for drug design","volume":"195","author":"Garrido","year":"2020","journal-title":"Eur J Med Chem"},{"issue":"7","key":"10.1016\/j.tcm.2023.03.006_bib0037","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1111\/j.1476-5381.2011.01688.x","article-title":"High potency inhibition of hERG potassium channels by the sodium-calcium exchange inhibitor KB-R7943","volume":"165","author":"Cheng","year":"2012","journal-title":"Br J Pharmacol"},{"issue":"5","key":"10.1016\/j.tcm.2023.03.006_bib0038","doi-asserted-by":"crossref","first-page":"e00160","DOI":"10.1002\/prp2.160","article-title":"Inhibition of hERG potassium channel by the antiarrhythmic agent mexiletine and its metabolite m-hydroxymexiletine","volume":"3","author":"Gualdani","year":"2015","journal-title":"Pharmacol Res Perspect"},{"issue":"5","key":"10.1016\/j.tcm.2023.03.006_bib0039","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jamainternmed.2020.0148","article-title":"Association of QT-prolonging medications with risk of autopsy-defined causes of sudden death","volume":"180","author":"Simpson","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"5","key":"10.1016\/j.tcm.2023.03.006_bib0040","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1159\/000492616","article-title":"Opioids and cardiac arrhythmia: a literature review","volume":"27","author":"Behzadi","year":"2018","journal-title":"Med Princ Pract"},{"issue":"5","key":"10.1016\/j.tcm.2023.03.006_bib0041","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/2042098612454283","article-title":"Drug-induced QT interval prolongation: mechanisms and clinical management","volume":"3","author":"Nachimuthu","year":"2012","journal-title":"Ther Adv Drug Saf"},{"issue":"6","key":"10.1016\/j.tcm.2023.03.006_bib0042","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1016\/j.bja.2018.12.023","article-title":"Opioid-induced respiratory depression in humans: a review of pharmacokinetic\u2013pharmacodynamic modelling of reversal","volume":"122","author":"Algera","year":"2019","journal-title":"Br J Anaesth"},{"issue":"7","key":"10.1016\/j.tcm.2023.03.006_bib0043","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.117.006035","article-title":"Human induced pluripotent stem cell\u2013derived engineered heart tissue as a sensitive test system for QT prolongation and arrhythmic triggers","volume":"11","author":"Lemoine","year":"2018","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"2","key":"10.1016\/j.tcm.2023.03.006_bib0044","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/toxsci\/kfz235","article-title":"Detection of drug-induced torsades de pointes arrhythmia mechanisms using hiPSC-CM syncytial monolayers in a high-throughput screening voltage sensitive dye assay","volume":"173","author":"da Rocha","year":"2020","journal-title":"Toxicol Sci"}],"container-title":["Trends in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173823000403?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173823000403?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T04:15:51Z","timestamp":1720671351000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1050173823000403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1050173823000403"],"URL":"https:\/\/doi.org\/10.1016\/j.tcm.2023.03.006","relation":{},"ISSN":["1050-1738"],"issn-type":[{"value":"1050-1738","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Opioids-induced inhibition of HERG ion channels and sudden cardiac death, a systematic review of current literature","name":"articletitle","label":"Article Title"},{"value":"Trends in Cardiovascular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tcm.2023.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}